Obesity continues to affect a disproportionately large number of people. With the prevalence of glucagon-like peptide-1 (GLP-1) drugs, more individuals are recognizing obesity for what it is: a chronic disease, rather than a condition caused by a lack of willpower. As GLP-1 uptake continues, weight management solutions, including structured weight management programs (SWMPs) like WeightWatchers (WW) and Noom, may still have a place in the shifting paradigm of obesity treatment. After all, although obesity medications initially disrupted SWMPs, growing evidence shows that patients should not neglect diet and exercise to achieve optimal, long-term results. SWMPs may also help address gaps in care that currently exist with overburdened primary care providers.
Read the full article: The Evolution of Structured Weight Management Programs //
Source: https://www.lek.com/insights/hea/us/ei/evolution-structured-weight-management-programs